StockData
Inogen Inc logo

Inogen Inc (INGN) stock

INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.57−0.11 (-2.02%)

Close on Nov 18, 2026Market cap $147.82MP/E –Yield –

Inogen operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Inogen's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.52M. For fiscal 2025 it was -$11.22M, down 289.7% from the year before. The highest annual figure on record is $60.49M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.22M-289.7%
FY2024Dec 31, 2024$5.91M–
FY2023Dec 31, 2023-$3.23M–
FY2022Dec 31, 2022-$37.53M-258.8%
FY2021Dec 31, 2021$23.63M-36.1%
FY2020Dec 31, 2020$37.01M-8.8%
FY2019Dec 31, 2019$40.59M-32.3%
FY2018Dec 31, 2018$59.98M-0.9%
FY2017Dec 31, 2017$60.49M+94.9%
FY2016Dec 31, 2016$31.03M-18.7%
FY2015Dec 31, 2015$38.16M+143.1%
FY2014Dec 31, 2014$15.70M+16.6%
FY2013Dec 31, 2013$13.47M+236.3%
FY2012Dec 31, 2012$4.00M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.95M-32.3%
Q1 FY2026Mar 31, 2026-$6.69M–
Q4 FY2025Dec 31, 2025-$943.00K–
Q3 FY2025Sep 30, 2025$2.17M-69.0%
Q2 FY2025Jun 30, 2025$4.35M-35.0%
Q1 FY2025Mar 31, 2025-$16.79M–
Q4 FY2024Dec 31, 2024-$3.02M–
Q3 FY2024Sep 30, 2024$6.99M+220.0%
Q2 FY2024Jun 30, 2024$6.69M+66.0%
Q1 FY2024Mar 31, 2024-$4.75M–
Q4 FY2023Dec 31, 2023-$3.15M–
Q3 FY2023Sep 30, 2023$2.19M–
Q2 FY2023Jun 30, 2023$4.03M-27.1%
Q1 FY2023Mar 31, 2023-$6.30M–
Q4 FY2022Dec 31, 2022-$15.48M-338.3%
Q3 FY2022Sep 30, 2022-$9.48M–
Q2 FY2022Jun 30, 2022$5.53M-68.0%
Q1 FY2022Mar 31, 2022-$18.10M-732.8%
Q4 FY2021Dec 31, 2021$6.50M-59.9%
Q3 FY2021Sep 30, 2021-$2.99M-144.4%
Q2 FY2021Jun 30, 2021$17.27M+27.6%
Q1 FY2021Mar 31, 2021$2.86M+429.6%
Q4 FY2020Dec 31, 2020$16.20M+72.5%
Q3 FY2020Sep 30, 2020$6.75M-53.8%
Q2 FY2020Jun 30, 2020$13.53M-26.6%
Q1 FY2020Mar 31, 2020$540.00K–
Q4 FY2019Dec 31, 2019$9.39M-23.9%
Q3 FY2019Sep 30, 2019$14.60M+1.6%
Q2 FY2019Jun 30, 2019$18.43M-12.3%
Q1 FY2019Mar 31, 2019-$1.82M-114.9%
Q4 FY2018Dec 31, 2018$12.34M-5.2%
Q3 FY2018Sep 30, 2018$14.38M-17.3%
Q2 FY2018Jun 30, 2018$21.02M+24.4%
Q1 FY2018Mar 31, 2018$12.24M-7.4%
Q4 FY2017Dec 31, 2017$13.01M+151.0%
Q3 FY2017Sep 30, 2017$17.38M+91.9%
Q2 FY2017Jun 30, 2017$16.90M–
Q1 FY2017Mar 31, 2017$13.21M–
Q4 FY2016Dec 31, 2016$5.18M–
Q3 FY2016Sep 30, 2016$9.06M–

More Inogen figures

See a number that looks wrong?